Clinical Trial Update: A Combined Biomarker Model for Risk Stratification of Indeterminate Pulmonary Nodules

View source ↗

Summary

A Vanderbilt-led clinical trial is evaluating a combined biomarker model to stratify risk for indeterminate pulmonary nodules and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Nodules

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Pulmonary Nodule | Status: RECRUITING